Clinical trial
PC-Trial: Patent Foramen Ovale and Cryptogenic Embolism
NCT00166257 · Foundation for Cardiovascular Research, Zurich, Other · Unknown status
Key facts
| NCT number | NCT00166257 |
|---|---|
| Title | PC-Trial: Patent Foramen Ovale and Cryptogenic Embolism |
| Official title | Randomized Clinical Trial Comparing the Efficacy of Percutaneous Closure of Patent Foramen Ovale (PFO) With Medical Treatment in Patients With Cryptogenic Embolism |
| Lead sponsor | Foundation for Cardiovascular Research, Zurich, Other |
| Collaborators | Abbott Medical Devices Industry |
| Status | Unknown status |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Embolism, Paradoxical, Heart Septal Defects, Atrial |
| Intervention type | Device, Drug |
| Interventions | Percutaneous closure of patent foramen ovale, Medical antitrhombotic treatment |
| Enrollment | 414 |
| Start date | Feb 1, 2000 |
| Primary completion | Feb 1, 2011 |
| Completion | May 1, 2011 |
| First posted | Sep 14, 2005 |
| Last update posted | May 27, 2009 |
| Countries | Australia, Austria, Belgium, Switzerland |
At a glance
- 1–9 Study sites
- No Results posted
- 1–9 Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: